WUXI XDC CAYMAN INC. · 药明合联
Last · HKSEHK$74.55-2.50 (-3.24%)close · yahoo · 7h ago
Market capHK$94.4B1.27B sh
P/E · TTM58.2fwd 29.3 · eps 1.28
Beta-0.87vs S&P 500
Div yield0.00%annual · TTM
52w range
HK$43.50HK$85.60
Volume7.2Msession
| Revenue | ¥6.9B |
|---|---|
| Operating income | ¥1.8B |
| Net income | ¥818.0M |
| Operating margin | 26.6% |
| Net margin | 11.8% |
| Return on equity | 7.1% |
| Period | TTM 2026-06-30 |
Loading chart…
Earnings transcripts
- Issuer webcast
2022 Annual Results Announcement Call
WUXI XDC CAYMAN INC.
- Issuer webcastVideo
2023 Interim Results Investor Call Time(57:50)
WUXI XDC CAYMAN INC.
- Issuer webcastAudio
41th Annual J.P. Morgan Healthcare Conference Presentation (Webcast) Time(39:24)
WUXI XDC CAYMAN INC.
- Issuer webcast
Presentations Webcasts
WUXI XDC CAYMAN INC.
Documents
FormReporting forFiledFlags